Produkty 142885-92-5

CAS 142885-92-5 występuje w naszej ofercie pod nazwami: 4-Methoxy-2-(((5-methoxy-1h-benzo[d]imidazol-2-yl)thio)methyl)-3,5-dimethylpyridine 1-oxide, 95%, Ufiprazole Impurity 1, Omeprazole Related Compound 10, Esomeprazole Impurity 66, Omeprazole sulfide N-Oxide, >95% (HPLC). Oferty producentów: Combi-blocks, Chemat Brand, Hubei YoungXin, TRC, Biosynth. Dostępne opakowania: 100mg, 250mg, on request, 10mg, 25mg, 50mg, 200mg, 500mg.

4-Methoxy-2-(((5-methoxy-1h-benzo[d]imidazol-2-yl)thio)methyl)-3,5-dimethylpyridine 1-oxide, 95%
Combi-blocks, Chemat Brand
  • opakowanie: 100mg, 250mg, on request
  • Warianty: 3
Zobacz produkt
Ufiprazole Impurity 1
Chemat Brand
  • opakowanie: on request
  • Warianty: 1
Zobacz produkt
Omeprazole Related Compound 10
Chemat Brand
  • opakowanie: on request
  • Warianty: 1
Zobacz produkt
Esomeprazole Impurity 66
Hubei YoungXin
  • opakowanie: 10mg, 25mg, 50mg, 100mg
  • Warianty: 5
Zobacz produkt
Omeprazole sulfide N-Oxide, >95% (HPLC)
TRC
  • opakowanie: 100mg, 10mg
  • Warianty: 2
Zobacz produkt
5-Methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)thio)-1H-benzimidazole N-oxide
Biosynth
  • opakowanie: 100mg, 250mg, 500mg, 1000mg
  • Warianty: 4
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

6-methoxy-2-[(4-methoxy-3,5-dimethyl-1-oxidopyridin-1-ium-2-yl)methylsulfanyl]-1H-benzimidazole (CAS 142885-92-5) to związek chemiczny o wzorze sumarycznym C17H19N3O3S i masie molowej 345.4 g/mol. Nazwa systematyczna IUPAC: 6-methoxy-2-[(4-methoxy-3,5-dimethyl-1-oxidopyridin-1-ium-2-yl)methylsulfanyl]-1H-benzimidazole. InChIKey: ZQAWPOQJXCJDPM-UHFFFAOYSA-N.

Dane identyfikacyjne
Wzór sumarycznyC17H19N3O3S
Masa molowa345.4 g/mol
Nazwa IUPAC6-methoxy-2-[(4-methoxy-3,5-dimethyl-1-oxidopyridin-1-ium-2-yl)methylsulfanyl]-1H-benzimidazole
InChIKeyZQAWPOQJXCJDPM-UHFFFAOYSA-N
SMILESCC1=C[N+](=C(C(=C1OC)C)CSC2=NC3=C(N2)C=C(C=C3)OC)[O-]

Dane obliczone przez PubChem (NCBI)

Synonimy: Omeprazole sulfide N-Oxide, Omeprazole Impurity 14
Izomery (ten sam wzór sumaryczny)
6-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methylsulfinyl]-1H-benzimidazole C17H19N3O3S
6-methoxy-2-[(R)-(4-methoxy-3,5-dimethyl-2-pyridinyl)methylsulfinyl]-1H-benzimidazole C17H19N3O3S
4,5,7-trideuterio-6-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methylsulfinyl]-1H-benzimidazole C17H19N3O3S
3-[[2-[[(R)-1H-benzimidazol-2-ylsulfinyl]methyl]-3-methyl-4-pyridinyl]oxy]propan-1-ol C17H19N3O3S
3-[[2-(1H-benzimidazol-2-ylsulfinylmethyl)-3-methyl-4-pyridinyl]oxy]propan-1-ol C17H19N3O3S
2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methylsulfinyl]-6-(trideuterio(113C)methoxy)-1H-benzimidazole C17H19N3O3S
2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methylsulfinyl]-6-(trideuteriomethoxy)-1H-benzimidazole C17H19N3O3S
2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methylsulfinyl]-6-(trideuteriomethoxy)-1H-benzimidazole C17H19N3O3S
2-[[3,5-dimethyl-4-(trideuteriomethoxy)-2-pyridinyl]methylsulfinyl]-6-(trideuteriomethoxy)-1H-benzimidazole C17H19N3O3S
1-[6-(3-methoxyphenyl)sulfanylpyridazin-3-yl]piperidine-3-carboxylic acid C17H19N3O3S